---
figid: PMC8995459__JCMM-26-2377-g005
pmcid: PMC8995459
image_filename: JCMM-26-2377-g005.jpg
figure_link: /pmc/articles/PMC8995459/figure/jcmm17258-fig-0006/
number: FIGURE 6
figure_title: ''
caption: EZH2 interacts with DNMT1 and HDAC1 to induce MEG3 silencing. A, B, Methylation
  of MEG3 promoter treated with 5 μm and 10 μm 5‐Aza for 48 h; C, Quantitative real‐time
  polymerase chain reaction (Q‐PCR) analysis of MEG3 in DMSO, 5 μm 5‐Aza and 10 μm
  5‐Aza groups; D, Q‐PCR analysis of MEG3 in DNMT1, DNMT3A and DNMT3B knockdown groups;
  E, Q‐PCR analysis of MEG3 in HDAC1 and HDAC2 knockdown groups; F, G, Q‐PCR analysis
  of MEG3 expression in DNMT1 and HDAC1 overexpression groups; H, I, Co‐IP for EZH2
  and DNMT1; J, K, Co‐IP for EZH2 and HDAC1; L, Western blot for the PRC2 complex,
  DNMT and HDAC in EZH2 knockdown, 48 h EZH2 inhibitor DZNep (5 and 10 μm) treatment
  and EZH2 overexpression groups compared with control; M, Western blot for EZH2,
  DNMT1 and HDAC1 in DZNep, SAHA and 5‐Aza treatment groups; N, Schematic diagram
  of the upstream regulatory molecular pathway of MEG3 (*p < 0.05, **p < 0.01, ***p < 0.001)
article_title: Downregulation of MEG3 and upregulation of EZH2 cooperatively promote
  neuroblastoma progression.
citation: Mujie Ye, et al. J Cell Mol Med. 2022 Apr;26(8):2377-2391.
year: '2022'

doi: 10.1111/jcmm.17258
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- epigenetics
- EZH2
- long non‐coding RNA
- MEG3
- neuroblastoma

---
